Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MODEL U-SES: 3-Month DAPT Discontinuation After Ultimaster Stent
jRCTs031180420Completed
- Sponsor
- Terumo
- Start
- Oct 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of aspirin, clopidogrel, prasugrel and ticagrelor in coronary arteriosclerosis (2 arms), sponsored by Terumo. Primary endpoint: Primary composite endpoint at 12 months. Started Oct 2016; status: completed.
02
Drugs
aspirinclopidogrelprasugrelticagrelor
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on jRCTs031180420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180420.